bf/NASDAQ:RARE_icon.jpeg

COM:ULTRAGENYX

Ultragenyx Pharmaceutical Inc.

  • Stock

USD

Last Close

46.02

22/11 21:00

Market Cap

3.85B

Beta: -

Volume Today

593.87K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
133K
-
2.61M
1,863.91%
51.49M
1,871.48%
103.71M
101.41%
271.03M
161.32%
351.41M
29.66%
363.33M
3.39%
434.25M
19.52%
cost of revenue
1K
-
1.15M
114,500%
9.01M
686.04%
6.13M
31.96%
16.01M
161.18%
28.32M
76.91%
45.21M
59.64%
gross profit
133K
-
2.61M
1,863.16%
50.35M
1,828.34%
94.71M
88.10%
264.90M
179.71%
335.40M
26.61%
335.01M
0.12%
389.04M
16.13%
selling and marketing expenses
general and administrative expenses
4.45M
-
10.81M
142.89%
33.00M
205.25%
64.94M
96.77%
99.91M
53.86%
127.72M
27.84%
selling general and administrative expenses
4.45M
-
10.81M
142.89%
33.00M
205.25%
64.94M
96.77%
99.91M
53.86%
127.72M
27.84%
161.52M
26.46%
182.93M
13.25%
219.98M
20.25%
278.14M
26.44%
309.80M
11.38%
research and development expenses
27.83M
-
45.97M
65.18%
114.74M
149.61%
183.20M
59.67%
231.64M
26.44%
294.00M
26.92%
357.36M
21.55%
412.08M
15.32%
497.15M
20.64%
705.79M
41.97%
648.45M
8.12%
other expenses
-3.01M
-
-3.02M
0.60%
-200K
93.39%
2.17M
1,184%
10.60M
389.11%
3.95M
62.71%
12.45M
214.90%
7.64M
38.60%
241K
96.85%
9.51M
3,845.23%
-337K
103.54%
cost and expenses
32.28M
-
56.78M
75.89%
147.74M
160.20%
248.14M
67.96%
331.55M
33.62%
422.87M
27.54%
527.89M
24.83%
601.15M
13.88%
733.14M
21.96%
1.01B
38.07%
1.00B
0.87%
operating expenses
32.28M
-
56.78M
75.89%
147.74M
160.20%
248.14M
67.96%
331.55M
33.62%
421.72M
27.20%
518.88M
23.04%
595.02M
14.67%
717.13M
20.52%
983.93M
37.20%
958.25M
2.61%
interest expense
1.14M
-
33.29M
2,833.13%
29.42M
11.62%
43.02M
46.20%
66.00M
53.44%
ebitda
-34.63M
-
-56.78M
63.98%
-146.35M
157.77%
-248.01M
69.46%
-328.94M
32.63%
-541.70M
64.68%
-411.72M
23.99%
-322.47M
21.68%
-381.50M
18.30%
-639.41M
67.61%
-516.85M
19.17%
operating income
-32.28M
-
-56.78M
75.89%
-147.74M
160.20%
-248.01M
67.87%
-328.94M
32.63%
-371.37M
12.90%
-424.17M
14.22%
-330.12M
22.17%
-381.74M
15.64%
-648.92M
69.99%
-569.21M
12.28%
depreciation and amortization
444K
-
684K
54.05%
1.38M
102.34%
3.42M
147.40%
5.83M
70.12%
19.54M
235.42%
12.45M
36.27%
7.64M
38.60%
241K
96.85%
9.51M
3,845.23%
26.01M
173.52%
total other income expenses net
-3.01M
-
-3.02M
0.60%
-200K
93.39%
2.17M
1,184%
10.60M
389.11%
174.28M
1,543.49%
24.73M
85.81%
144.76M
485.37%
-71.24M
149.22%
-52.81M
25.88%
-39.26M
25.66%
income before tax
-35.07M
-
-59.80M
70.52%
-145.62M
143.50%
-245.84M
68.82%
-318.34M
29.49%
-197.10M
38.09%
-399.44M
102.66%
-185.36M
53.60%
-452.98M
144.38%
-701.73M
54.91%
-608.46M
13.29%
income tax expense
-3.01M
-
-684K
77.25%
-2.32M
239.18%
35K
101.51%
-16.20M
46,382.86%
514K
103.17%
3.28M
538.72%
1.21M
63.23%
1.04M
13.50%
5.70M
445.59%
-1.82M
132.04%
net income
-35.07M
-
-59.80M
70.52%
-145.62M
143.50%
-245.87M
68.85%
-302.14M
22.88%
-197.61M
34.60%
-402.73M
103.80%
-186.57M
53.67%
-454.02M
143.36%
-707.42M
55.81%
-606.64M
14.25%
weighted average shs out
29.06M
-
28.76M
1.05%
36.78M
27.91%
39.59M
7.62%
42.45M
7.24%
49.78M
17.25%
56.58M
13.66%
60.85M
7.54%
67.80M
11.42%
69.91M
3.13%
73.54M
5.19%
weighted average shs out dil
29.06M
-
28.76M
1.05%
36.78M
27.91%
39.59M
7.62%
42.45M
7.24%
49.78M
17.25%
56.58M
13.66%
60.85M
7.54%
67.80M
11.42%
69.91M
3.13%
73.54M
5.19%
eps
-1.21
-
-2.08
71.90%
-3.96
90.38%
-6.21
56.82%
-7.12
14.65%
-3.97
44.24%
-7.12
79.35%
-3.07
56.88%
-6.70
118.24%
-10.12
51.04%
-8.25
18.48%
epsdiluted
-1.21
-
-2.08
71.90%
-3.96
90.38%
-6.21
56.82%
-7.12
14.65%
-3.97
44.24%
-7.12
79.35%
-3.07
56.88%
-6.70
118.24%
-10.12
51.04%
-8.25
18.48%

All numbers in USD (except ratios and percentages)